147 related articles for article (PubMed ID: 33371687)
1. Self-Assembling Derivative of Hydrocortisone as Glucocorticoid Receptor-Targeted Nanotherapeutics for Synergistic, Combination Therapy against Colorectal Tumor.
Sridharan K; Rathore B; Yousuf M; Reddy Rachamalla HK; Jinka S; Jaggarapu MMCS; Banerjee R
Mol Pharm; 2021 Mar; 18(3):1208-1228. PubMed ID: 33371687
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid receptor-targeted liposomal delivery system for delivering small molecule ESC8 and anti-miR-Hsp90 gene construct to combat colon cancer.
Jinka S; Rachamalla HK; Bhattacharyya T; Sridharan K; Sekhar Jaggarapu MMC; Yakati V; Banerjee R
Biomed Mater; 2021 Feb; 16(2):024105. PubMed ID: 33434900
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid receptor mediated sensitization of colon cancer to photodynamic therapy induced cell death.
Chilakamarthi U; Mahadik NS; Bhattacharyya T; Gangadhar PS; Giribabu L; Banerjee R
J Photochem Photobiol B; 2024 Feb; 251():112846. PubMed ID: 38237432
[TBL] [Abstract][Full Text] [Related]
4. Synergistic anti-tumor effects of Liraglutide, a glucagon-like peptide-1 receptor agonist, along with Docetaxel on LNCaP prostate cancer cell line.
Eftekhari S; Montazeri H; Tarighi P
Eur J Pharmacol; 2020 Jul; 878():173102. PubMed ID: 32283060
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid receptor-mediated delivery of nano gold-withaferin conjugates for reversal of epithelial-to-mesenchymal transition and tumor regression.
Agarwalla P; Mukherjee S; Sreedhar B; Banerjee R
Nanomedicine (Lond); 2016 Oct; 11(19):2529-46. PubMed ID: 27622735
[TBL] [Abstract][Full Text] [Related]
6. 15-Deoxy-Delta12,14-prostaglandin J2 enhances docetaxel anti-tumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors.
Fulzele SV; Chatterjee A; Shaik MS; Jackson T; Ichite N; Singh M
Anticancer Drugs; 2007 Jan; 18(1):65-78. PubMed ID: 17159504
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid Receptor-Targeted Liposomal Codelivery of Lipophilic Drug and Anti-Hsp90 Gene: Strategy to Induce Drug-Sensitivity, EMT-Reversal, and Reduced Malignancy in Aggressive Tumors.
Mondal SK; Jinka S; Pal K; Nelli S; Dutta SK; Wang E; Ahmad A; AlKharfy KM; Mukhopadhyay D; Banerjee R
Mol Pharm; 2016 Jul; 13(7):2507-23. PubMed ID: 27184196
[TBL] [Abstract][Full Text] [Related]
8. Role of nonsteroidal anti-inflammatory drug-activated gene-1 in docetaxel-induced cell death of human colorectal cancer cells with different p53 status.
Kim IY; Park SY; Kang Y; Thapa D; Choi HG; Kim JA
Arch Pharm Res; 2011 Feb; 34(2):323-30. PubMed ID: 21380817
[TBL] [Abstract][Full Text] [Related]
9. Luteinizing hormone-releasing hormone receptor-targeted deslorelin-docetaxel conjugate enhances efficacy of docetaxel in prostate cancer therapy.
Sundaram S; Durairaj C; Kadam R; Kompella UB
Mol Cancer Ther; 2009 Jun; 8(6):1655-65. PubMed ID: 19509261
[TBL] [Abstract][Full Text] [Related]
10. Trans-scirpusin A showed antitumor effects via autophagy activation and apoptosis induction of colorectal cancer cells.
Hong EH; Heo EY; Song JH; Kwon BE; Lee JY; Park Y; Kim J; Chang SY; Chin YW; Jeon SM; Ko HJ
Oncotarget; 2017 Jun; 8(25):41401-41411. PubMed ID: 28489607
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of docetaxel anticancer activity by a novel diindolylmethane compound in human non-small cell lung cancer.
Ichite N; Chougule MB; Jackson T; Fulzele SV; Safe S; Singh M
Clin Cancer Res; 2009 Jan; 15(2):543-52. PubMed ID: 19147759
[TBL] [Abstract][Full Text] [Related]
12. Bis-arylidene oxindoles for colorectal cancer nanotherapy.
Bhattacharyya T; Mishra T; Das D; Adhikari SS; Banerjee R
Bioorg Chem; 2024 May; 146():107294. PubMed ID: 38507997
[TBL] [Abstract][Full Text] [Related]
13. Co-delivery of Docetaxel and Disulfonate Tetraphenyl Chlorin in One Nanoparticle Produces Strong Synergism between Chemo- and Photodynamic Therapy in Drug-Sensitive and -Resistant Cancer Cells.
Gaio E; Conte C; Esposito D; Miotto G; Quaglia F; Moret F; Reddi E
Mol Pharm; 2018 Oct; 15(10):4599-4611. PubMed ID: 30148955
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional tumor-targeting nanocarriers based on hyaluronic acid-mediated and pH-sensitive properties for efficient delivery of docetaxel.
Song S; Chen F; Qi H; Li F; Xin T; Xu J; Ye T; Sheng N; Yang X; Pan W
Pharm Res; 2014 Apr; 31(4):1032-45. PubMed ID: 24154802
[TBL] [Abstract][Full Text] [Related]
15. Piperine and Celecoxib synergistically inhibit colon cancer cell proliferation via modulating Wnt/β-catenin signaling pathway.
Srivastava S; Dewangan J; Mishra S; Divakar A; Chaturvedi S; Wahajuddin M; Kumar S; Rath SK
Phytomedicine; 2021 Apr; 84():153484. PubMed ID: 33667839
[TBL] [Abstract][Full Text] [Related]
16. Synergistic anti-proliferative effects of gambogic acid with docetaxel in gastrointestinal cancer cell lines.
Zou Z; Xie L; Wei J; Yu L; Qian X; Chen J; Wang T; Liu B
BMC Complement Altern Med; 2012 Apr; 12():58. PubMed ID: 22546220
[TBL] [Abstract][Full Text] [Related]
17. Insulin enhancement of the antitumor activity of chemotherapeutic agents in colorectal cancer is linked with downregulating PIK3CA and GRB2.
Agrawal S; Woźniak M; Łuc M; Makuch S; Pielka E; Agrawal AK; Wietrzyk J; Banach J; Gamian A; Pizon M; Ziółkowski P
Sci Rep; 2019 Nov; 9(1):16647. PubMed ID: 31719636
[TBL] [Abstract][Full Text] [Related]
18. Dual drug loaded liposome bearing apigenin and 5-Fluorouracil for synergistic therapeutic efficacy in colorectal cancer.
Sen K; Banerjee S; Mandal M
Colloids Surf B Biointerfaces; 2019 Aug; 180():9-22. PubMed ID: 31015105
[TBL] [Abstract][Full Text] [Related]
19. Gambogic acid induces apoptosis and inhibits colorectal tumor growth via mitochondrial pathways.
Huang GM; Sun Y; Ge X; Wan X; Li CB
World J Gastroenterol; 2015 May; 21(20):6194-205. PubMed ID: 26034354
[TBL] [Abstract][Full Text] [Related]
20. Exploring the Promising Potential of High Permeation Vesicle-Mediated Localized Transdermal Delivery of Docetaxel in Breast Cancer To Overcome the Limitations of Systemic Chemotherapy.
Bathara M; Date T; Chaudhari D; Ghadi R; Kuche K; Jain S
Mol Pharm; 2020 Jul; 17(7):2473-2486. PubMed ID: 32496783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]